BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17077019)

  • 21. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes.
    Nagai T; Arinuma Y; Yanagida T; Yamamoto K; Hirohata S
    Arthritis Rheum; 2005 Mar; 52(3):847-55. PubMed ID: 15751081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Arthritis Rheum; 2007 Jan; 56(1):303-10. PubMed ID: 17195234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus.
    Kanda N; Watanabe S
    J Allergy Clin Immunol; 2000 Mar; 105(3):532-40. PubMed ID: 10719304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The in vitro production and regulation of anti-double stranded DNA antibodies by peripheral blood mononuclear cells from normals and patients with systemic lupus erythematosus.
    Mach PS; Kharouby M; Lutcher F; Olivier JL; Bazely N; Dougados M; Amor B
    Clin Exp Immunol; 1984 Aug; 57(2):338-44. PubMed ID: 6331922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE).
    Monsiváis-Urenda A; Niño-Moreno P; Abud-Mendoza C; Baranda L; Layseca-Espinosa E; López-Botet M; González-Amaro R
    J Autoimmun; 2007; 29(2-3):97-105. PubMed ID: 17601702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression.
    Tanaka Y; Saito K; Suzuki H; Eto S; Yamashita U
    J Immunol; 1989 Sep; 143(5):1584-90. PubMed ID: 2527267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus.
    Koarada S; Tada Y; Ushiyama O; Morito F; Suzuki N; Ohta A; Miyake K; Kimoto M; Nagasawa K
    Arthritis Rheum; 1999 Dec; 42(12):2593-600. PubMed ID: 10616005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta.
    Flescher E; Fossum D; Ballester A; Maizel A; Sharma S; Talal N
    Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of recombination activating genes 1 and 2 in peripheral B cells of patients with systemic lupus erythematosus.
    Girschick HJ; Grammer AC; Nanki T; Vazquez E; Lipsky PE
    Arthritis Rheum; 2002 May; 46(5):1255-63. PubMed ID: 12115231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
    Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression.
    Korganow AS; Knapp AM; Nehme-Schuster H; Soulas-Sprauel P; Poindron V; Pasquali JL; Martin T
    J Autoimmun; 2010 Jun; 34(4):426-34. PubMed ID: 19963348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling.
    Kono H; Kyogoku C; Suzuki T; Tsuchiya N; Honda H; Yamamoto K; Tokunaga K; Honda Z
    Hum Mol Genet; 2005 Oct; 14(19):2881-92. PubMed ID: 16115811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B cell receptor signaling in human systemic lupus erythematosus.
    Pugh-Bernard AE; Cambier JC
    Curr Opin Rheumatol; 2006 Sep; 18(5):451-5. PubMed ID: 16896281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal T cell regulation of IgG synthesis in systemic lupus erythematosus.
    Nies KM; Stevens RH; Louie JS
    J Clin Lab Immunol; 1980 Sep; 4(2):69-75. PubMed ID: 6449594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.
    Linker-Israeli M; Deans RJ; Wallace DJ; Prehn J; Ozeri-Chen T; Klinenberg JR
    J Immunol; 1991 Jul; 147(1):117-23. PubMed ID: 2051017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.